title: Trevogrumab
text: # Trevogrumab
  
  Trevogrumab (INN; development code REGN1033) is a human monoclonal antibody designed for the treatment of muscle atrophy due to orthopedic disuse and sarcopenia.
  
  This drug was developed by Regeneron Pharmaceuticals, Inc.
  
  